Breast cancer can be categorized into different histopathological subtypes based on gene expression profiles. This study aimed to classify the molecular subtypes of breast cancers based on the expression profile of immunohistochemical markers and to evaluate the clinicopathological features, relapse free survival (RFS) and overall survival (OS) of various subtypes of breast cancer in order to help diagnosis and guide treatment. The results of this study showed the importance of clinicopathological studies of molecular types which helps to understand better the pathophysiology of disease and to identify the best strategy to treat the disease.
Olfa Zoukar. Professor in Obstetrics Gynecology. Maternity and Neonatal Center of the Fattouma Bourguiba University Hospital in Monastir Tunisia.
Number of Pages:
Éditions universitaires européennes
Breast cancer ; Hormonal receptors ; Immunohistochemical ; Relapse; Molecular classification ; Survival
LAW / General